Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Listed on GrantGunner. Last checked 23 Oct 2026.

About this grant

R21 grants to support clinical trial readiness activities for rare diseases. The program aims to encourage rare disease research by supporting efficient and effective movement of candidate therapies or diagnostics toward clinical trials and to increase their chance of success. Organized by NCATS in collaboration with NICHD.

Who can apply

Applicants must be eligible to apply for NIH R21 grants; specific eligibility not detailed in scraped pages.

Browse all open grants

More grants from National Center for Advancing Translational Sciences